Chemoinformaics analysis of Cyclooctanepentanoic Acid
| Molecular Weight | 212.333 | nRot | 5 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 9 |
| Exact Molecular Weight | 212.178 | nRing | 1 |
| Solubility: LogS | -3.704 | nHRing | 0 |
| Solubility: LogP | 4.773 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 39.317 |
| nHD | 1 | BPOL | 24.945 |
| QED | 0.699 |
| Synth | 1.756 |
| Natural Product Likeliness | 0.551 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.259 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.897 |
| MDCK | 0.0000325 |
| BBB | 0.288 |
| PPB | 0.971238 |
| VDSS | 0.375 |
| FU | 0.0106552 |
| CYP1A2-inh | 0.145 |
| CYP1A2-sub | 0.22 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.189 |
| CYP2c9-inh | 0.279 |
| CYP2c9-sub | 0.98 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.115 |
| CYP3a4-inh | 0.027 |
| CYP3a4-sub | 0.033 |
| CL | 1.973 |
| T12 | 0.699 |
| hERG | 0.022 |
| Ames | 0.006 |
| ROA | 0.014 |
| SkinSen | 0.795 |
| Carcinogencity | 0.096 |
| EI | 0.979 |
| Respiratory | 0.735 |
| NR-Aromatase | 0.034 |
| Antiviral | Yes |
| Prediction | 0.783135 |